EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prolonged prophylactic antibiotic regimens may reduce periprosthetic infection in megaprosthetic reconstruction: a case series

Ricarda Stauss, Fabian Bugdoll, Tilman Graulich, Lars-René Tuecking, Peter Savov, Max Ettinger, Mohamed Omar

Archives of Orthopaedic and Trauma Surgery · 19.11.2026 · 146 (1)

DOI: 10.1007/s00402-026-06567-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, online erschienen am 19.11.2026. Verfasst von Ricarda Stauss und 6 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carl von Ossietzky Universität Oldenburg.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Megaprosthetic reconstruction (MPR) is associated with a substantially higher risk of periprosthetic joint infection (PJI) compared to primary total joint arthroplasty. However, evidence guiding the optimal duration of antibiotic prophylaxis remains limited, and institutional practices vary considerably. The purpose of this study was to evaluate the incidence of PJI, antibiotic-related complications, and surgical outcomes in patients undergoing MPR followed by a prolonged prophylactic antibiotic regimen. Materials and methods This retrospective single-centre study included patients undergoing MPR between May 2020 and November 2022 at a tertiary sarcoma referral centre. All patients received a standardised postoperative 12-week prophylactic antibiotic regimen consisting of two weeks of intravenous ampicillin/sulbactam followed by 10 weeks of oral rifampin and levofloxacin. The primary outcome was the incidence of PJI. Secondary outcomes included surgery-related complication and revision rates, antibiotic-related adverse events, and mortality.

Results

A total of 47 patients were included into the study, of which 83% underwent MPR for oncologic conditions. The overall PJI rate was 2.1% at a mean follow-up of 39 months. Surgery-related complications occurred in 4.3%, and the revision rate was 4.3%. No antibiotic-related adverse events were documented during inpatient treatment or follow-up. All-cause mortality was 21.3%.

Conclusions

In this retrospective case series, a low incidence of PJI was observed in patients undergoing MPR followed by a standardised 12-week prophylactic antibiotic regimen. Thus, these findings might support the notion that extended prophylaxis could be a safe and effective strategy in high-risk patients undergoing MPR. However, the study design, limited sample size and absence of a control group restrict the conclusions that can be drawn from these findings, and comparative prospective studies are required to determine the effectiveness of prolonged antibiotic prophylaxis following MPR.

Förderung

  • Carl von Ossietzky Universität Oldenburg

Zitieren

APA

Stauss, R., Bugdoll, F., Graulich, T., Tuecking, L., Savov, P., Ettinger, M., & Omar, M. (2026). Prolonged prophylactic antibiotic regimens may reduce periprosthetic infection in megaprosthetic reconstruction: a case series. Archives of Orthopaedic and Trauma Surgery, 146(1). https://doi.org/10.1007/s00402-026-06567-y

Vancouver

Stauss R, Bugdoll F, Graulich T, Tuecking L, Savov P, Ettinger M, et al. Prolonged prophylactic antibiotic regimens may reduce periprosthetic infection in megaprosthetic reconstruction: a case series. Archives of Orthopaedic and Trauma Surgery. 2026;146(1). doi:10.1007/s00402-026-06567-y

BibTeX
@article{Stauss2026,
  author = {Stauss, Ricarda and Bugdoll, Fabian and Graulich, Tilman and Tuecking, Lars-René and Savov, Peter and Ettinger, Max and Omar, Mohamed},
  title = {Prolonged prophylactic antibiotic regimens may reduce periprosthetic infection in megaprosthetic reconstruction: a case series},
  journal = {Archives of Orthopaedic and Trauma Surgery},
  year = {2026},
  volume = {146},
  number = {1},
  doi = {10.1007/s00402-026-06567-y}
}
Kostenlos starten →